Hexokinase is a family of enzymes that catalyze the ATP-dependent phosphorylation of hexose sugars, primarily glucose, to form glucose-6-phosphate, marking the initial and rate-limiting step of glycolysis in mammalian cells.[1] This reaction traps glucose within the cell and directs it toward metabolic pathways for energy production, biosynthesis, and storage.[2] In mammals, hexokinases are essential for maintaining cellular energy homeostasis and responding to nutrient availability across diverse tissues.[3]Mammalian hexokinases comprise four primary isoforms—HK1, HK2, HK3, and HK4 (also known as glucokinase)—each with distinct molecular weights, kinetic properties, and tissue distributions.[3] HK1, HK2, and HK3 are 100 kDa proteins evolved from tandem duplication of a 50 kDa ancestral gene, featuring N-terminal and C-terminal halves that both contribute to catalytic activity, particularly in HK2.[2] HK1 is ubiquitously expressed but predominates in the brain and erythrocytes, where it exhibits high glucose affinity (low Km); HK2 is enriched in insulin-sensitive tissues like skeletal muscle, heart, and adipose, and is inducible by insulin; HK3 shows broad but low-level expression with reduced catalytic efficiency; and HK4, a monomeric 50 kDaenzyme, is liver- and pancreas-specific, functioning as a glucose sensor with lower affinity (higher Km) to regulate blood glucose levels postprandially.[1] All isoforms are subject to product inhibition by glucose-6-phosphate, though HK4 is less sensitive, allowing sustained activity at high glucose concentrations.[2]Beyond their core metabolic function, hexokinases exhibit moonlighting roles in cellular signaling and protection, decoupling enzymatic activity from regulatory effects in some contexts. HK1 and HK2 associate with the mitochondrial outer membrane via the voltage-dependent anion channel (VDAC), enhancing glycolytic flux by providing direct access to mitochondrially generated ATP while inhibiting apoptosis by blocking pro-death proteins like Bax and the permeability transition pore.[3] HK2, in particular, is phosphorylated by Akt at Thr-473 to strengthen this mitochondrial binding, conferring cytoprotection during stress such as ischemia.[3] Additionally, HK2 can regulate autophagy by interacting with mTORC1 under glucose-limiting conditions to inhibit its activity and induce autophagy, linking nutrient sensing to cellular adaptation.[3] HK4 senses glucose to trigger insulin secretion in pancreatic β-cells and glycogen synthesis in hepatocytes, pivotal for systemic glucose homeostasis.[1]Hexokinases are dysregulated in various pathologies, most notably in cancer, where HK2 overexpression drives the Warburg effect—characterized by increased aerobic glycolysis to support rapid proliferation despite oxygen availability.[1] This isoform's mitochondrial localization further promotes tumor cell survival by evading apoptosis.[3] Mutations or deficiencies in hexokinases, such as in HK1-related hemolytic anemia or HK4-associated maturity-onset diabetes of the young (MODY2), underscore their clinical significance.[1]
Reaction and Mechanism
Catalyzed Reaction
Hexokinase catalyzes the phosphorylation of hexoses, primarily glucose, using ATP as the phosphate donor to form glucose-6-phosphate (G6P) and ADP.[4] This irreversible reaction represents the first committed step in hexosemetabolism and is driven by the hydrolysis of the high-energy phosphoanhydride bond in ATP.[5] The general equation is:
Glucose+ATP→Glucose-6-phosphate+ADP
The enzyme exhibits broad substrate specificity, accommodating various hexoses beyond glucose, including mannose, fructose, and glucosamine, which allows it to phosphorylate structurally similar sugars with modifications at the C2 or C3 positions.[6] This versatility is evident in both eukaryotic and prokaryotic forms, where the enzyme's active site tolerates these substrates, though relative activities vary.[6]The catalytic mechanism involves an induced-fit model: glucose binds first to the open conformation of the enzyme, causing the two lobes (N- and C-terminal domains in mammalian isoforms) to close around the substrates, positioning ATP (with Mg²⁺ cofactor) for phosphate transfer to the C6 hydroxyl of glucose. Conserved residues, such as aspartate, facilitate the reaction via hydrogen bonding and transition state stabilization.